Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer ; day:26 ; month:4 ; year:2017 ; pages:1-6
Breast cancer research and treatment ; (26.4.2017), 1-6
- Keyword
-
Krebs
Onkologie
- Creator
-
Sheri, A.
- Contributor
-
Smith, I. E.
Hills, M.
Jones, R. L.
Johnston, S. R.
Dowsett, M.
SpringerLink (Online service)
- DOI
-
10.1007/s10549-017-4266-9
- URN
-
urn:nbn:de:1111-201705089013
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sheri, A.
- Smith, I. E.
- Hills, M.
- Jones, R. L.
- Johnston, S. R.
- Dowsett, M.
- SpringerLink (Online service)
Other Objects (12)
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer